forsal.pl · November 4, 2026
Government bill would double discount on Polish-made reimbursed drugs to 30%
A government reform bill submitted to the Sejm would raise the patient co-payment discount from 15% to 30% for drugs whose product and active substance are both made in Poland. It is to take effect on 1 January 2027. The discount is calculated from the base co-payment: for 100 zloty, patients would pay 70 zloty instead of 85.